AntBio: 2025 AACR Meeting - Charting New Oncology Frontiers Together
AntBio cordially invites you to attend the 2025 AACR Annual Meeting and jointly chart a new course in oncology research!
The global benchmark for cancer research and therapeutics—the 2025 American Association for Cancer Research (AACR) Annual Meeting—will commence in the U.S. on April 25th! As an antibody expert in the life sciences field, AntBio will showcase high-quality, high-performance antibody products and innovative one-step ELISA kits at this premier international event. We sincerely invite you to visit our booth (Booth No.: 4744) to engage in face-to-face discussions with our expert team and explore the future of cancer diagnostics and therapeutics together!
Conference Details
Date: April 25–30, 2025 (5 days)
Venue: McCormick Place Convention Center, Chicago, USA
Booth No.: 4744 (Location map below)
About AntBio
AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are commonly used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.
The mIHC kits, organoid culture kits, conventional and One-step ELISA assay kits, RNA/DNA/protein interaction kits, as well as a number of primary antibodies and recombinant protein tool products, have been popular and wildly used in the research market and supporting scientists accelerating innovation and productivity.
AntBio looks forward to meeting you at AACR 2025!